HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cross-reactivity of the 31 kDa antigen of Angiostrongylus cantonensis - Dealing with the immunodiagnosis of meningoencephalitis.

Abstract
The primary causative agent of eosinophilic meningoencephalitis (EoM) in endemic regions is the nematode Angiostrongylus cantonensis. The occurrence of EoM was previously restricted to countries in Southeast Asia and the Pacific Islands; however, more recently, it has been reported from other regions, including Brazil. The commonly used diagnosis is detection of specific antibody reactivity to the 31 kDa antigen, which is derived from female worm somatic extracts. Here we report the occurrence of cross-reactivity to this antigen in sera from other parasitic infections, especially those that may cause EoM, such as gnathostomiasis, toxocariasis, hydatidosis and strongyloidiasis. We also demonstrated that the cross-reactivity, in part, is dependent of the concentration of antigen used in Western blot assays. We discuss the importance of these findings on the interpretation of this test.
AuthorsAlessandra L Morassutti, Lisa N Rascoe, Sukwan Handali, Alexandre J DA Silva, Patricia P Wilkins, Carlos Graeff-Teixeira
JournalParasitology (Parasitology) Vol. 144 Issue 4 Pg. 459-463 (04 2017) ISSN: 1469-8161 [Electronic] England
PMID27866477 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Helminth
Topics
  • Angiostrongylus cantonensis (immunology, metabolism)
  • Animals
  • Antigens, Helminth (immunology)
  • Cross Reactions
  • Humans
  • Meningoencephalitis (blood, diagnosis, parasitology)
  • Strongylida Infections (diagnosis, immunology, parasitology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: